Exome Asset Management LLC
Position in CRBP — Corbus Pharmaceuticals Holdings, Inc.
CIK 2011932
NEW YORK, NY
Position in CRBP
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,734,493
-$464,044 QoQ
Shares Held
184,914
-21.0% QoQ
Ownership
0.956%
of shares outstanding
% of Portfolio
1.07%
of 13F equity value
Holder Rank
#15
of 106 holders
Holding Since
Mar 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CRBP Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Exome Asset Management LLC holds $110,788,985 across 37 Biotechnology names. CRBP ranks #23 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PRAX |
Praxis Precision Medicines, Inc.
|
27,205 | $9,107,961 | |
| 2 | TGTX |
Tg Therapeutics, Inc.
|
164,915 | $9,060,430 | |
| 3 | COGT |
Cogent Biosciences, Inc.
|
210,523 | $8,147,240 | |
| 4 | IONS |
Ionis Pharmaceuticals Inc
|
88,177 | $6,991,554 | |
| 5 | ABVX |
Abivax S.A.
|
46,878 | $6,246,962 | |
| 6 | ALMS |
Alumis Inc.
|
204,418 | $5,752,322 | |
| 7 | CYTK |
Cytokinetics Inc
|
60,056 | $5,116,170 | |
| 8 | ELVN |
Enliven Therapeutics, Inc.
|
100,203 | $5,085,302 |
All Filings in CRBP
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,734,493 | 184,914 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,198,537 | 234,136 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,135,880 | 139,543 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,909,019 | 229,962 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,913,487 | 277,317 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $1,538,253 | 289,690 | Shares | Sole | 2025-05-16 | |
| 2024-06-30 | $3,836,747 | 84,790 | Shares | Sole | 2024-10-03 | |
| 2024-03-31 | $3,447,077 | 87,846 | Shares | Sole | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||